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Background: There is a need for interventions to promote uptake of breast screening throughout Europe.
Methods: We performed a single-blind randomised controlled trial to test whether text-message reminders were effective. Two
thousand two hundred and forty women receiving their first breast screening invitation were included in the study and randomly
assigned in a 1 : 1 ratio to receive either a normal invitation only (n¼ 1118) or a normal invitation plus a text-message reminder 48 h
before their appointment (n¼ 1122).
Results: In the intention-to-treat analysis, uptake of breast screening was 59.1% among women in the normal invitation group and
64.4% in the text-message reminder group (w2¼ 6.47, odds ratio (OR): 1.26, 95% confidence intervals (CI): 1.05–1.48, P¼ 0.01). Of
the 1122 women assigned to the text-message reminder group, only 456 (41%) had a mobile number recorded by their GP and
were thereby sent a text. In the per-protocol analysis, uptake by those in the control group who had a mobile number recorded on
the GP system was 59.77% and by those in the intervention group who were sent a reminder 71.7% (w2¼ 14.12, OR¼ 1.71, 95%
CI¼ 1.29–2.26, Po0.01).
Conclusions: Sending women a text-message reminder before their first routine breast screening appointment significantly
increased attendance. This information can be used to allocate resources efficiently to improve uptake without exacerbating social
inequalities.
Breast cancer is a major public health concern in Europe, one
accounting for 28.8% of all female cancer incidences (Ferlay et al,
2010), and 16.8% of all female cancer deaths (Ferlay et al, 2013).
Survival is strongly contingent on a number of important genetic
and clinical factors, among the most predictive of which are the
stage and grade of the tumour upon diagnosis (Huang et al, 2003;
Onitilo et al, 2009; American Cancer Society, 2012). As such,
chances of survival are improved greatly when breast cancer is
detected early, something which has been enabled through routine
mammography screening (Independent UK Panel on Breast
Cancer Screening, 2012).
The effectiveness of routine screening to improve breast cancer
outcomes however depends not only on the ability of the screening
test to detect early stage cancers, but also on the ability of the
programme to attract the at-risk population (Lynge et al, 2012).
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Screening recommend that uptake should be at least 70%, and
ideally475% (Giordano et al, 2012); however, in a recent analysis
of 26 European breast cancer screening programmes, only half of
those studied achieved a level of uptake that was equal to or greater
than the European benchmark for acceptable participation
(Giordano et al, 2012). Suboptimal participation in breast cancer
screening has been a topic of concern for some time, and,
accordingly, there has been much interest in understanding the
reasons underpinning low uptake, as well as in the development of
novel interventions to promote participation and reduce missed
appointment rates (Spadea et al, 2007; Walton, 2009; Jensen
et al, 2012).
Detailed surveys issued to non-attenders and their health-care
providers have identified the most prevalent patient-related factors
for missing a breast screening appointment as: ‘inadequate
knowledge and understanding of the breast screening test’
(Berner et al, 2001), ‘feeling embarrassed about having the test’,
‘having a lack of breast cancer symptoms’, ‘residing in a deprived
area’, ‘the profession of the health-care provider making the
referral’ and ‘forgetting to go to the appointment’ (Crump et al,
2000). ‘Forgetting to go to the appointment’ was the single most
frequently cited reason for not attending a routine breast screen,
accounting for 19–31% of missed appointments (Crump et al,
2000; Aro et al, 2001; Baysal and Gozum, 2011). Interventions that
address ‘forgetting to go to the appointment’ then, such as
reminders, might offer a potential solution for preventing a large
number of missed appointments, thereby improving uptake
without infringing upon a person’s ability to make an informed
choice.
Previous studies that have examined the use of reminders to
prevent missed breast screening appointments report that both
telephone and postal reminders are effective, but that neither are
affordable nor sustainable (Taplin et al, 1999; Goelen et al, 2010).
By comparison, text messaging (also referred to as short messaging
service) offers a relatively inexpensive, instantaneous and ubiqui-
tous modality for delivering reminders (Ofcom, 2012). In other
areas of health care, text messages reminding the patient about the
time, date and venue of their appointment have been shown not
only to be an acceptable alternative for delivering reminders but
also a preferable one (Cohen et al, 2007; Hanauer et al, 2009;
Kharbanda et al, 2009). Thus, text messaging may offer an
affordable and desirable solution for delivering reminders for
routine breast screening appointments.
Although a recent meta-analysis of randomised controlled trials
(RCTs) and observational studies found that text messages
reminding patients of their appointments are effective in promot-
ing clinic attendance (Guy et al, 2012), with no significant
subgroup differences between the timing of the reminder at 24, 48
and 72 h (Guy et al, 2012), there have been no published RCTs
evaluating the effectiveness of text-message reminders to promote
the uptake of breast screening in an otherwise healthy population.
We identified one RCT that investigated whether longer, more
informative text messages were more effective than shorter, less
informative text messages at promoting self-referral rates among
previous non-attenders, but the study did not compare rates with
receiving no reminder for routine appointments (Lakkis et al,
2011). Despite the lack of high-quality evidence, some Breast
Cancer Screening Centres have opted to implement text messaging
systems to deliver reminders for routine screening appointments
(Lakkis et al, 2011); this, however, is not an evidence-based
practice, and the resources invested in these services might be
utilised better elsewhere.
In this study, we performed an RCT to evaluate the effectiveness
(intention-to-treat analysis; ITT) and efficacy (per-protocol
analysis; PP) of text messaging as a novel mechanism for delivering
reminders for routine breast screening appointments, and to
provide evidence to inform European Guidelines for Quality
Assurance in Breast Cancer Screening on how best to invest the
resources presently being spent on text-messaging services.
The primary aim was to establish whether text-message
reminders improved uptake and reduced missed appointments
for the prevalent breast screening round in a diverse setting, where
uptake is below the National and European target.
MATERIALS AND METHODS
Study design and management. The text-message reminder study
(TMRS) was a two-arm, single-blind, RCT. The study was
undertaken in the London Borough of Hillingdon (LBH) by the
Hillingdon Primary Care Trust and the West of London Breast
Screening Service (WoLBSS) between November 2012 and October
2013.
Study setting. The setting of our study, the LBH, is one that
routinely fails to reach the European target of 70%, and, as with the
rest of London, the breast screening service has found it difficult to
encourage attendance here (Giordano et al, 2012; NHS Cancer
Screening Programmes, 2012). In the previous screening round
(2011–2012), uptake in the LBH fell short of the European target
for acceptable participation at 67%. Similar to many London
settings, the LBH is ethnically diverse, with 52.2% of residents
being of white British ethnicity, and serves patients from a range of
socioeconomic areas (Office for National Statistics, 2012).
Participants. The only eligibility criterion was appearance on the
list of women (ages 47–53 years) who were due to be invited for
their first routine breast screen in the LBH during the trial period
(November 2012–October 2013). All interval cancer cases, GP
referrals, self-referrals, male appointments and other non-routine
appointments were excluded from the trial. The study was
designed to test for a one-tailed difference in attendance of 5%,
with 80% power and a 5% margin of error. A sample size of 1117
participants per condition was derived using a standard test for
comparing two proportions (the w2 test with Yates’ continuity
correction), giving a total sample size requirement of 2234 (Witte
and Witte, 2013).
Procedures. Although this study represented only a minor
variation on routine practice, and some UK breast screening
centres are already offering text-message reminders for routine
appointments, women entered into the trial were informed that
they were participants in a study and given the option to withdraw.
Women received an information letter about the trial, which
included an opt-out request slip, with their breast screening
invitation. The trial was approved by the East Midlands National
Research Ethics Service and the review boards of the participating
organisations, which included the Local Medical Committee for
Hillingdon, the Hillingdon Clinical Commissioning Group and the
West London NHS Research and Development Group. The study
was carried out in accordance with Good Clinical Practice
guidelines and the Declaration of Helsinki and registered with
the ClinicalTrials.Gov RCT database for transparency.
Participants were randomised via computerised pseudorandom
allocation methods to one of two trial arms in a 1 : 1 ratio. All
women were sent the standard breast screening invitation letter
normally used by the WoLBSS 3–4 weeks before their appoint-
ment. All women included in the trial received the study letter and
opt-out request slip, irrespective of which arm of the trial they had
been assigned to.
Women assigned to the ‘control arm’ (1) were invited to breast
screening in a standard office hour appointment, without
reminder, as per usual care. Women assigned to the intervention
arm (2) were also invited to a standard office hour appointment;
however, they additionally received a text-message reminder 48 h
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before their appointment, which included the time, date and venue
of their appointment, as well as information about rescheduling if
unable to attend (see Supplementary Information).
Women who cancelled or who did not attend (DNA) and did
not reschedule their breast screening appointment were sent a
‘DNA letter’ by the WoLBSS, again, as per usual care. The DNA
letter extends an open invitation to the non-attender, offering them
an 8-week window to book an appointment. Participants in the
text-message reminder arm (2) who DNA their breast screening
examination also received an additional ‘DNA text message’, which
repeated key information from the DNA letter about booking a
new appointment (see Supplementary Information). Women in the
intervention group who went on to schedule a new appointment
were also sent a text-message reminder for that appointment
(again, this was sent 48 h before the appointment).
Text-message reminders were delivered via iPlato patient care
messaging (PCM), a cloud-based communication platform speci-
fically developed for health services (iPlato, 2013). iPlato PCM was
integrated with the clinical system of the participating GP practices
included in the breast screening round plan for the duration of the
study, which enabled automated reminders to be sent remotely
using the mobile telephone numbers stored on the online server.
No attempts to obtain mobile numbers for participants who had
none recorded on the GP clinical system at the time of the study
were made so as to ensure the ecological validity of the ITT.
The primary study end point was attendance at first appoint-
ment offered. The secondary end point was attendance 60 days
after the first appointment was offered, to test whether any
differences in attendance between groups were sustained after non-
attenders had a chance to schedule a new appointment in response
to the DNA letter/DNA text message. The primary interest was the
difference in uptake between the two study arms.
Data collection and analysis. Breast screening end codes available
on the Breast Cancer Screening System were used to verify
attendance at the initial appointment and again 60 days thereafter.
At the end of the study, the data was analysed using the statistical
analysis software package: ‘IBM SPSS Statistics 22’. Differences in
attendance rates between the control and intervention arms and
other binary or ordinal data were examined using the w2 test; odds
ratios (ORs) and 95% confidence intervals (CIs) were also
calculated (Witte and Witte, 2013), with attendance at breast
screening as the outcome variable and assigned study group as the
exposure. To explore possible variations of the impact of the
intervention in relation to age and social deprivation, a logistic
regression was carried out (Vernon et al, 1990). For this purpose, a
composite indicator of area-based socioeconomic deprivation for
each postcode sector was derived using the 2010 Index of Multiple
Deprivation. Ethnic background was not included in the regression
analysis owing to sparseness in the data (ethnicity was only known
for those women who went to their appointment and provided it).
RESULTS
Between November 2012 and October 2013, a total of 2294 women
were enrolled into the TMRS. Fifty-four (2.35%) returned an opt-
out request and were subsequently removed from the trial. This
resulted in a total of 2240 women being included, of whom 1118
were randomly allocated to the control arm (1) and 1122 to the
text-message reminder arm (2). Figure 1 shows the CONSORT
diagram for the flow of the participants through the trial. Table 1
shows the basic attributes of the study participants. All women
included in the study were aged 47–53 years and in the prevalent
round for breast screening. Participants were from a range of
socioeconomic areas (Table 1).
Intention-to-treat analysis. Attendance at first appointment
offered was significantly higher among women assigned to the
text-message reminder arm of the study than the no-reminder arm
(64.35% vs 59.12%; w2¼ 6.47, OR¼ 1.26, 95% CI¼ 1.05–1.48,
P¼ 0.01; Table 2A); attendance remained significantly higher at
follow-up, 60 days after the initial appointment was offered
(67.65% vs 62.88%; w2¼ 5.61, OR¼ 1.23, 95% CI¼ 1.04–1.47,
P¼ 0.02; Table 2A). The number of women cancelling an
appointment was also significantly higher in the text-message
reminder arm of the trial than the no-reminder arm (5.44% vs
2.77%; w2¼ 10.09, OR¼ 2.02, 95% CI¼ 1.30–3.13, Po0.01;
Table 2A).
Accuracy and availability of patient mobile numbers (preva-
lence). Of the 1122 women assigned to the text-message reminder
arm of the trial, only 456 (40.6%) had a mobile telephone number
recorded on the GP clinical system (Table 3), of which 76 (17.6%)
had expired and were no longer valid. The remaining 380 numbers
were active, and only these women received a text-message
reminder for their appointment. For the purposes of the per-
protocol (PP) analysis, we compared uptake between women in the
control arm of the trial who had a mobile number recorded on
their GPs’ clinical system, with women in the intervention arm
who had a mobile number recorded on the GP clinical system.
Because women in the control arm of the trial did not receive a text
message as part of this study, we were unable to verify the validity
of their mobile numbers, and consequently elected to include those
in the intervention group who had an invalid mobile telephone
number in the analysis, so as to avoid incurring any unnecessary
bias.
Regression analysis: mobile prevalence among the study cohort.
Overall, mobile prevalence of the TMRS cohort was 39.8%
(Table 3). Mobile prevalence did not differ significantly between
age groups (OR¼ 0.97, 95% CI¼ 0.82–1.16, P¼ 0.74; Table 3) nor
between trial arms (OR¼ 1.08, 95% CI¼ 0.91–1.28, P¼ 0.36;
Table 3), but was socioeconomically graded (OR¼ 1.25, 95%
CI¼ 1.16–1.34, Po0.001; Table 3), ranging from 48.0% in the least
deprived quintile of areas (QoAs) to 31.1% in the most deprived.
2294 Women invited to breast screening
54 Opt-out cases
2240 Women randomly allocated
1118 Women allocated to receive 
no reminder (1)
1122 Women allocated to receive
a reminder (2)
Figure 1. Basic design of the study and number of participants
randomised.
Table 1. Description of the trial population
n %
Age (years)
47–49 896 40
50–53 1344 60
Quintile of deprivation (IMD score)
1 (0–9.87) 369 16.5
2 (9.88–14.60) 555 24.8
3 (14.61–21.61) 539 24.1
4 (21.62–33.49) 645 28.8
5 (33.50–100) 132 5.9
Mobile phone number recorded on GP system
Mobile record on GP system 891 39.8
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Per-protocol analysis. In the PP analysis, attendance at the first
appointment offered was significantly higher among women
assigned to the text-message reminder arm of the study, who did
have a mobile number recorded on their GPs’ clinical system, than
the no reminder arm (71.71% vs 59.77%; w2¼ 14.12, OR¼ 1.71,
95% CI¼ 1.29–2.26, Po0.01; Table 2B). In addition, attendance
remained significantly higher at follow-up, 60 days after the initial
appointment was offered (73.90% vs 62.53%; w2¼ 13.32,
OR¼ 1.70, 95% CI¼ 1.28–2.26, Po0.01; Table 2B). The number
of women cancelling an appointment was also significantly higher
in the text-message reminder arm of the trial than the no-reminder
arm (6.80% vs 2.30%; w2¼ 10.27, OR¼ 3.10, 95% CI¼ 1.50–6.40,
Po0.01; Table 2B).
Regression analysis: attendance at first appointment. Overall,
attendance at first appointment was 61.1% (Table 4). Attendance
did not differ significantly between age groups (61% vs 62.2%;
OR¼ 1.05, 95% CI¼ 0.884–1.25, P¼ 0.55), but was, however,
socially graded (OR¼ 0.80, 95% CI¼ 0.74–0.86, Po0.001), ran-
ging from 70.2% among women living in the least deprived QoAs
to 53.6% in the second most deprived (Table 4).
On an ITT basis, women living in the most deprived QoAs
demonstrated the greatest benefits from receiving a text-message
reminder before their first appointment, with an absolute increase
in attendance at first appointment offered of 13.6%, a relative
increase of 28% (Table 4), despite poor mobile records within this
group (Table 3).
DISCUSSION
The results of this RCT are very clear. First, on an ITT basis, we
found that sending women a text message reminding them of the
time, day and venue of their first routine breast screening
appointment, 48 h before the appointment, significantly increased
attendance at the first appointment offered (64.35% vs 59.12%).
Second, attendance remained significantly higher 60 days after
non-attenders in both groups received a ‘DNA letter’, and in the
text-message reminder group, an additional ‘DNA text message’
(67.65% vs 62.88%). On a PP basis, the benefits of receiving
reminders for routine breast screening appointments by text
message were even more apparent: 71.71% vs 59.77% at first
appointment offered; 73.9% vs 62.5% within 60 days of the first
appointment offered. From the PP analysis, we were able to
identify that one of the major limitations of text-message
reminders to promote the uptake of breast screening further as:
‘suboptimal patient mobile telephone records’; out of 1122
participants assigned to the text-message reminder group, only
456 (40.6%) had a mobile telephone number recorded on their
GPs’ clinical system, and thereby sent a reminder.
Subgroup analyses by QoAs indicate that women living in the
most deprived QoAs benefited the most from receiving a text-
message reminder before their appointment, despite having the
poorest mobile records. Among this group, attendance at the first
appointment offered increased by 13.6% on an ITT basis (a relative
increase of 28%). Increasing the attendance of women living in the
most deprived areas is of particular importance, as these women
are less likely to participate in screening, are more likely to engage
in negative health behaviours (i.e. more likely to smoke, less likely
to engage in regular exercise and more likely to eat less fruit and
vegetables on average per day) and more likely to be diagnosed
later with breast cancer with poorer prognosis for survival than
Table 2B. Attendance at first appointment offered (primary end point), attendance within 60 days of first appointment offered
(secondary end point) and per cent cancelling an appointment by trial arm: per-protocol analysis
Measure
Subgroup of the control
population that had a mobile
number recorded on the GP
system (n¼435)
Subgroup of the intervention
population that had a mobile
number recorded on the GP
system (n¼456) Difference v2
Primary end point: attendance (at first appointment offered) 59.77% (260) 71.71% (327) 14.12**
Secondary end point: attendance (within 60 days of first
appointment offered)
62.53% (272) 73.90% (337) 13.32**
% Cancelled appointment 2.30% (10) 6.80% (31) 10.27*
*Po0.05; **Po0.001.
Table 2A. Attendance at first appointment offered (primary end point), attendance within 60 days of first appointment offered
(secondary end point) and per cent cancelling an appointment by trial arm: intention-to-treat analysis
Measure
Trial arm (1): routine invitation
only (n¼1118)
Trial arm (2): routine invitation with a
text-message reminder (n¼1122) Difference v2
Primary end point: attendance (at first appointment
offered)
59.12% (661) 64.35% (722) 6.47*
Secondary end point: attendance (within 60 days of
first appointment offered)
62.88% (703) 67.65% (759) 5.61*
% Cancelled appointment 2.77% (31) 5.44% (61) 10.09*
*Po0.05.
Table 3. Mobile prevalence and logistic regression analysis
Comparisons
Mobile
prevalence % (n) OR (95% CI) P-value
Overall prevalence 39.8% (891/2240) — —
Trial arm
Controla 38.9% (435/1118) — —
Intervention 41% (456/1122) 1.08 (0.91–1.28) 0.36
Age group (years)
47–49a 40.3% (361/896) — —
50–52 39.4% (530/1344) 0.97 (0.82–1.16) 0.74
Quintile of deprivation
Quintile 1a 48.0% (177/369) — —
Quintile 2 44.5% (247/555) 0.85 (0.65–1.10) 0.34
Quintile 3 41.4% (223/539) 0.64 (0.43–0.96) 0.027
Quintile 4 31.6% (203/645) 0.56 (0.37–0.84) 0.004
Quintile 5 31.1% (41/132) 0.49 (0.32–0.74) 0.001
Abbreviations: CI¼ confidence interval; OR¼odds ratio.
aReference category.
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women from less deprived areas (Vernon et al, 1990; Sutton et al,
1994; Shohaimi et al, 2003, 2004; Bouchardy et al, 2006).
The findings of this study are comparable to those of previous
trials investigating the use of more conventional and costly reminders
to promote the uptake of breast screening (Taplin et al, 1999;
Walton, 2009; Goelen et al, 2010). The finding that text-message
reminders improve breast screening attendance is consistent with
previous research investigating the use of text-message reminders to
enhance attendance in other areas of health care, such as
ophthalmology and paediatric dentistry (Guy et al, 2012); however,
to our knowledge, the finding that reminders are particularly effective
for increasing attendance among patients from deprived areas is
completely novel (Guy et al, 2012), as is the finding that patients who
receive a reminder by text message are more likely to telephone to
cancel their appointment, rather than not attend.
Strengths and limitations. This is the first RCT examining the
question of whether text-message reminders increase the uptake of
breast cancer screening. As such, it is the first study to show that
these are effective without being vulnerable to bias and confound-
ing data present in previously published studies.
The setting of our study, the LBH, is one that routinely fails to
reach the European target of 70%, serves an ethnically diverse
population from a range of socioeconomic areas, and, as with the
rest of London, the breast screening service has found it difficult to
encourage attendance here. These results are likely to be
generalisable to other London boroughs and international urban
settings struggling to reach the 70% target.
By investigating the effectiveness of text-message reminders to
improve the uptake of the first invitation population only, we are able
to eliminate previous response to a breast screening invite as a
confounding factor, as it has previously been described in the
literature (Vernon et al, 1990). However, because we explored the
effectiveness of text-message reminders to promote uptake of the first
invitation population only, our results are not necessarily generalisable
to the incident population. Having said this, previous research has
demonstrated that women attending their first breast screening
appointment are more likely to attend incident rounds of screening
than women who DNA (Lakkis et al, 2011), thus enhancing uptake by
the first invitation population is of particular interest and may have
lasting benefit on participation throughout incident screening rounds.
The main limitation of this study is that it was not designed to
test for differences in attendance between subgroups of the
population. As such, the number of participants within each QoAs
is too few for any definitive conclusions to be made, and such
findings may not be robust. In addition, because participants were
informed that they were being included in an experimental trial,
the results may not be ecologically valid, as this information may
have affected the participants’ decision to attend mammography.
To avoid any unnecessary demand characteristics arising in the
intervention group, participants were told they were being included
in an experimental trial, irrespective of whether they were assigned
to receive a reminder or not.
Implications of results. The findings of this study have both
national and international implications for the future practice of
breast screening. Sending women a text message to remind them of
the time, date and venue of their first breast screen could have a
substantial impact on women’s health through the early detection
and treatment of benign and malignant breast disease, without
impeding on the autonomy of the patient to make an informed
choice. The study shows that text messages may be a promising
intervention in increasing the uptake of women from deprived areas,
thus reducing the social gradient. However, an RCT with a larger
sample of participants with mobile numbers from varying quintiles is
needed to test this hypothesis. Furthermore, text-message reminders
could potentially save breast screening services money through
improved efficiency (i.e. fewer missed appointments because of
increased patient cancellations and increased uptake); however, a
cost-effectiveness analysis is needed to confirm this. Text-message
reminders are cheap, effective and easy to implement; improving GP
practice records of patient mobile numbers would have benefits for
screening as well as other clinic appointments, and it is plausible that
text message reminders could be used to increase participation in
other cancer screening programmes. Again, further research testing
this hypothesis may be required.
CONCLUSION
Sending women a text message to remind them of the time, date and
venue of their first routine breast screening appointment significantly
Table 4. Attendance and logistic regression analysis
Comparisons Primary end point: attendance % (n) OR (95% CI) P-value
Overall attendance 61.7% (1383/2240) — —
Trial arm
Controla 59.12% (661/1118) — —
Intervention 64.35% (722/1122) 1.25 (1.05–1.48) 0.01
Age group (years)
47–49a 61.0% (547/896) — —
50–52 62.2% (836/1344) 1.05 (0.884–1.25) 0.55
Quintile of deprivation
Quintile 1a 70.2% (259/369) — —
Quintile 2 67.4% (374/555) 0.88 (0.66–1.17) 0.37
Quintile 3 61.4% (331/539) 0.68 (0.51–0.90) o0.01
Quintile 4 53.6% (346/645) 0.49 (0.37–0.64) o0.01
Quintile 5 55.3% (73/132) 0.53 (0.35–0.80) o0.01
Quintile of deprivation by trial arm
Controla Intervention
Quintile 1 73.4% (138/188) 66.9% (121/181) 0.73 (0.47–1.15) 0.18
Quintile 2 62.5% (173/277) 72.3% (201/278) 1.56 (1.09–2.23) 0.02
Quintile 3 59.6% (161/270) 63.2% (170/269) 1.16 (0.82–1.64) 0.42
Quintile 4 49.5% (157/317) 57.6% (189/328) 1.39 (1.02–1.89) 0.04
Quintile 5 48.5% (32/66) 62.1% (41/66) 1.75 (0.88–3.51) 0.11
Abbreviations: CI¼ confidence interval; OR¼odds ratio.
aReference category.
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increased uptake without exacerbating social health inequalities.
This information can be used to achieve an improved level
of uptake, where uptake is below the National or International
target.
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